Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in people aged 65 years and over in the North East of England, April 2006-July 2012

Trials in Vaccinology

Volumn 2, Issue 1, 2013, Pages 45-48

  Wright, L B ^a   Hughes, G J ^a   Chapman, K E ^a   Gorton, R ^a   Wilson, D ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

23 Valent pneumococcal polysaccharide vaccine; Aged 65 years; Invasive pneumococcal disease; North East England; Vaccine effectiveness

Indexed keywords

PNEUMOCOCCUS VACCINE;

AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; UNITED KINGDOM; VACCINATION;

EID: 84889080843     PISSN: None     EISSN: 18794378     Source Type: Journal    
DOI: 10.1016/j.trivac.2013.09.004     Document Type: Article

References (18)

1. Health Protection Agency. General Information on Pneumococcal Disease. [Online]. Available from: http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/ HPAweb-C/1203008864027. (Accessed January 2013).
2. K. Chapman, D. Wilson, and R. Gorton Invasive Pneumococcal Disease in the North East: 2006-2010 Report 2012 Health Protection Agency North East Regional Epidemiology Unit
3. Department of Health Immunisation against infectious disease Green Book 25 2012 295 313
4. A. Huss, P. Scott, A.E. Stuck, C. Trotter, and M. Egger Efficacy of pneumococcal vaccination in adults: a meta-analysis Can. Med. Assoc. J. 180 1 2009 48 58
5. A. Vila-Corcoles, E. Salsench, T. Rodriguez-Blanco, O. Ochoa-Gondar, C. de Diego, and A. Valdivieso Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study Vaccine 27 10 2008 1504 1510
6. N.J. Andrews, P.A. Waight, R.C. George, M.P.E. Slack, and E. Miller Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales Vaccine 30 48 2012 6802 6808
7. J.D. Mooney, A. Weir, J. McMenamin, L.D. Ritchie, T.V. Macfarlane, and C.R. Simpson The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004 BMC Infect. Dis. 8 2008 53
8. C.V. Broome, R.R. Facklam, and D.W. Fraser Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine N. Engl. J. Med. 303 1980 549 552 (Pubitemid 10046830)
9. L.A. Jackson, and E.N. Janoff Pneumococcal vaccination of elderly adults: new paradigms for protection Clin. Infect. Dis. 47 2008 1329 1338
10. World Health Organisation. 23-valent pneumococcal polysaccharide vaccine: WHO position paper. [Online]. Available from: http://www.who.int/wer/2008/ wer8342.pdf. (Accessed February 2013).
11. K.L. O'Brien, M. Hochman, and D. Goldblatt Combined schedules of pneumococcal conjugate and polysaccharide vaccines: us hyporesponsiveness an issue? Lancet Infect Dis. 7 2007 597 606 (Pubitemid 47268225)
12. S. Moberley, J. Holden, D.P. Tatham, and R.M. Andrews Vaccines for preventing pneumococcal infection in adults Cochrane Database Syst. Rev. 1 2013
13. E.D. Shapiro, and J.D. Clemens A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections Ann. Intern. Med. 101 3 1984 325 330 (Pubitemid 14033779)
14. R.V. Sims, W.C. Steinmann, J.H. McConville, L.R. King, W.C. Zwick, and J.S. Schwartz The clinical effectiveness of pneumococcal vaccine in the elderly Ann. Intern. Med. 108 1988 653 657
15. K.E. Chapman, D. Wilson, and R. Gorton Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England Epidemiol. Infect. 1 1 2012 1 9
16. R.J. Singleton, J.C. Butler, L.R. Bulkow, D. Hurlburt, K.L. O'Brien, and W. Doan Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska Native adults Vaccine 25 12 2007 2288 2295 (Pubitemid 46227693)
17. S. Moberley, V. Krause, H. Cook, K. Mulholland, J. Carapetis, and P. Torzillo Failure to vaccinate or failure of vaccine? Effectiveness of the 23-valent pneumococcal polysaccharide vaccine program in Indigenous adults in the Northern Territory of Australia Vaccine 28 11 2010 2296 2301
18. D. McLennan, H. Barnes, M. Noble, J. Davies, E. Garratt, and C. Dibben The English Indices of Deprivation 2010 2011 Department for Communities and Local Government London [Online]. Available from: http://www.communities.gov.uk/ documents/statistics/pdf/1870718.pdf. (Accessed May 2013)